Tekla Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$10.6M Hold
2022
Q2
$10.2M Hold
2022
Q1
$8.32M Hold
2021
Q4
$9.67M Sell
2021
Q3
$12.6M Buy
2020
Q4
Sell
2020
Q3
$2.23M Hold
2020
Q2
$2.51M Sell
2020
Q1
$1.54M Buy
2019
Q4
$1.59M Hold
2019
Q3
$1.22M Buy
2018
Q2
Sell
2018
Q1
$4.18M Buy